News

As per the terms of the agreement, OctoPlus is expected to perform process development and clinical manufacturing for The Medicines Company related to MDCO-216 (ApoA-I Milano/phospholipid complex). MDCO-216

Xcelodose is a registered trademark of Capsugel, a division of Pfizer. Penn Pharma and Xcelience claimed that the joint venture provides pharmaceutical and biotechnology companies the opportunity to

Daiichi Sankyo has presented results of the study at the 21st International Congress on Thrombosis (ICT) in Milan, Italy. Daiichi Sankyo’s Phase III STARS E-3 study, in Japan

The trial trial was designed to determine if preoperative administration of NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel (AC-T) results in at least a doubling

Caldolor study was a double-blind, placebo-controlled malaria trial that evaluated 60 adults with acute uncomplicated falciparum malaria who were treated with artemisinin combination therapy. In the study, patients

As per the terms of the agreement, with this two year extension, Galapagos is expected to be eligible to receive up to $8.6m. BioFocus runs a compound management

The extremolyte Ectoin (1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid) is a cyclic amino acid that is produced mainly by halophilic bacteria to protect the cells from the extreme osmotic stress associated with

The survivin protein is believed to be important in the growth and survival of cancer cells and is over-expressed in common cancers, such as melanoma, prostate, pancreatic, colorectal

Protalix BioTherapeutics said that the FDA has granted taliglucerase alfa a standard review time of 10 months, assigning a prescription drug user fee act (PDUFA) action date of